These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32926424)

  • 41. A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.
    Gong J; Ou J; Qiu X; Jie Y; Chen Y; Yuan L; Cao J; Tan M; Xu W; Zheng F; Shi Y; Hu B
    Clin Infect Dis; 2020 Jul; 71(15):833-840. PubMed ID: 32296824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognosis models for severe and critical COVID-19 based on the Charlson and Elixhauser comorbidity indices.
    Zhou W; Qin X; Hu X; Lu Y; Pan J
    Int J Med Sci; 2020; 17(15):2257-2263. PubMed ID: 32922189
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.
    Liu D; Lan L; Luo D; Zhao B; Wei G; He Y; Zhang R; Liu Y
    Diabetes Res Clin Pract; 2020 Sep; 167():108341. PubMed ID: 32707212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study.
    Myrstad M; Ihle-Hansen H; Tveita AA; Andersen EL; Nygård S; Tveit A; Berge T
    Scand J Trauma Resusc Emerg Med; 2020 Jul; 28(1):66. PubMed ID: 32660623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity.
    Aloisio E; Chibireva M; Serafini L; Pasqualetti S; Falvella FS; Dolci A; Panteghini M
    Arch Pathol Lab Med; 2020 Dec; 144(12):1457-1464. PubMed ID: 32649222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China.
    Zhang SY; Lian JS; Hu JH; Zhang XL; Lu YF; Cai H; Gu JQ; Ye CY; Jin CL; Yu GD; Jia HY; Zhang YM; Sheng JF; Li LJ; Yang YD
    Infect Dis Poverty; 2020 Jul; 9(1):85. PubMed ID: 32641121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting severe or critical symptoms in hospitalized patients with COVID-19 from Yichang, China.
    Chen X; Peng F; Zhou X; Zhu J; Chen X; Gong Y; Shupeng W; Niu W
    Aging (Albany NY); 2020 Dec; 13(2):1608-1619. PubMed ID: 33318316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thoracic imaging tests for the diagnosis of COVID-19.
    Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD
    Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipidome is a valuable tool for the severity prediction of coronavirus disease 2019.
    Zhang SS; Zhao Z; Zhang WX; Wu R; Li F; Yang H; Zhang Q; Wei TT; Xi J; Zhou Y; Wang T; Du J; Huang N; Ge Q; Lu QB
    Front Immunol; 2024; 15():1337208. PubMed ID: 38799463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Derangements of biochemical markers and thyroid function analysis among COVID-19-positive patients: A developing country single-center experience.
    Asghar MS; Yasmin F; Dapke K; Phadke R; Shah SMI; Bin Zafar MD
    J Med Virol; 2021 Oct; 93(10):5712-5717. PubMed ID: 34213779
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity?
    Conca W; Alabdely M; Albaiz F; Foster MW; Alamri M; Alkaff M; Al-Mohanna F; Nagelkerke N; Almaghrabi RS
    PLoS One; 2021; 16(3):e0247758. PubMed ID: 33647017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients.
    Ponti G; Roli L; Oliva G; Manfredini M; Trenti T; Kaleci S; Iannella R; Balzano B; Coppola A; Fiorentino G; Ozben T; Paoli VD; Debbia D; De Santis E; Pecoraro V; Melegari A; Sansone MR; Lugara M; Tomasi A
    Clin Chem Lab Med; 2021 Aug; 59(9):e354-e357. PubMed ID: 33768762
    [No Abstract]   [Full Text] [Related]  

  • 58. Peripheral biomarkers' panel for severe COVID-19 patients.
    d'Alessandro M; Bergantini L; Cameli P; Curatola G; Remediani L; Sestini P; Bargagli E;
    J Med Virol; 2021 Mar; 93(3):1230-1232. PubMed ID: 33006404
    [No Abstract]   [Full Text] [Related]  

  • 59. Association between inflammation, angiopoietins, and disease severity in critically ill COVID-19 patients: a prospective study.
    Abou-Arab O; Bennis Y; Gauthier P; Boudot C; Bourdenet G; Gubler B; Beyls C; Dupont H; Kamel S; Mahjoub Y
    Br J Anaesth; 2021 Mar; 126(3):e127-e130. PubMed ID: 33423740
    [No Abstract]   [Full Text] [Related]  

  • 60. Leukocyte glucose index as a novel biomarker for COVID-19 severity.
    Ramos-Hernández WM; Soto LF; Del Rosario-Trinidad M; Farfan-Morales CN; De Jesús-González LA; Martínez-Mier G; Osuna-Ramos JF; Bastida-González F; Bernal-Dolores V; Del Ángel RM; Reyes-Ruiz JM
    Sci Rep; 2022 Sep; 12(1):14956. PubMed ID: 36056114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.